Scale -

  • Revenue is 2276 Rs Cr; Annual Growth is 33 %; Continuous Growth over 3 years; 5 Year CAGR is 30 %; in Bottom Quartile
  • PBT is 50.75 Rs Cr; Annual Growth is 61 %; 5 Year CAGR is 32 %; in Bottom Quartile
  • PAT is 188 Rs Cr; Annual Growth is 62 %; 5 Year CAGR is 32 %; in Bottom Quartile
  • Ebitda is 291 Rs Cr; 5 Year CAGR is 30 %; in Bottom Quartile
  • Quarterly Ebitda is 48.94 Rs Cr; in Bottom Quartile

Profitability -

  • PAT Margin is 8.24 %; Annual Growth is 22 %; in Bottom Quartile
  • PBDIT Margin is 12.76 %; Annual Decline is -26 %; in Bottom Quartile
  • Quarterly Ebitda Margin is 7 %; in Bottom Quartile
  • Quarterly Profit margin is 6 %; in Bottom Quartile

Return -

  • ROA is 9.42 %; Annual Growth is 24 %
  • ROE is 21.48 %; Annual Growth is 43 %; in Top Quartile; 5 Year CAGR is 16 %
  • ROCE is 26 %; in Top Quartile
  • Asset Turnover is 130 %; in Top Quartile

Efficiency -

  • Inventory Turnover Ratio is 2.89; 5 Year CAGR is 48 %; Annual Decline is -35 %; in Bottom Quartile
  • Quick Ratio is 0.73; Annual Decline is -35 %; Continuous Decline over 3 years; in Bottom Quartile
  • Operating cash flow is -15.14 Rs Cr; Annual Decline is -123 %; in Bottom Quartile
  • Current Ratio is 1.77; Continuous Decline over 3 years

Solvancy -

  • Debt/Equity is 0; in Bottom Quartile
  • Total Debt is 0 Rs Cr; in Bottom Quartile
  • Contingent Liabilities is 122 Rs Cr; in Bottom Quartile

Quality -

  • Current Tax/PAT is 32 %; Annual Decline is -39 %
  • Change in Inventories/Total Expenses is -24 %; Continuous Decline over 3 years; in Bottom Quartile
  • Other Expenses/Total Expenses is 18 %; in Bottom Quartile
  • Operating cashflow/ebitda is -5 %; Annual Decline is -123 %; in Bottom Quartile
  • Operating cashflow/PAT is -8 %; Annual Decline is -114 %; in Bottom Quartile
  • Exceptional Items/PBT is -2 %; Annual Growth is 97 %

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector
Major Subsidiaries/Associates
Key Clients

Products

Products
Product details

Operations

Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
AstraZeneca Strengthens India Presence with New Mumbai Corporate Office
Read More
  • Past/current
AstraZeneca Pharma India announces new Mumbai corporate office, marking the next phase of growth through innovation
Read More
  • Past/current